Quest Test Gets First FDA Green Light for Sample Pooling to Detect SARS-CoV-2 by Glenn S. Demby | Aug 4, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Top of the News-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
Payors Gradually Increasing Coverage of Liquid Biopsies but Obstacles Remain by Glenn S. Demby | Jul 28, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Reimbursement-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Provides New Guidance on Validation of Sample Pooling for SARS-CoV-2 Test Development by Glenn S. Demby | Jul 20, 2020 | Articles, Essential, FDA-nir, National Lab Reporter... This content is for Paid Members only.RegisterAlready a member? Log in here
Feds Launch First COVID-19 Testing Fraud Prosecution by Glenn S. Demby | Jul 3, 2020 | Articles, DOJ-lca, Essential, False Claims-lca, Lab Compliance Advisor... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Sets the Bar on Specimen Pooling & Asymptomatic Screening for SARS-CoV-2 Test Development by Glenn S. Demby | Jun 22, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here